News|Articles|November 17, 2026

US loses measles elimination status; CDC outlines re-elimination plan

Fact checked by: Benjamin P. Saylor

Key Takeaways

  • PAHO revoked US measles elimination status in November 2026 after determining transmission had continued for more than 12 months; CDC had counted 5,412 confirmed cases in 2026 as of November 12.
  • CDC and HHS continue to recommend MMR vaccination as the most effective prevention, and CDC has directed about $100 million to state and local health departments for outbreak prevention and response.
SHOW MORE

The US lost measles elimination status after 26 years; CDC and partners plan to regain it via MMR vaccination and $100M in health department funding.

The United States no longer meets the international definition of measles elimination, a designation it had held since 2000, and federal health officials are positioning measles, mumps, and rubella (MMR) vaccination as the main route back. In a joint statement released November 17, 2026, the CDC and national public health partners outlined plans to stop ongoing outbreaks and regain elimination status by promoting MMR vaccination, expanding vaccine access, closing protection gaps, and equipping state and local health departments.¹

"The measles elimination designation is not what protects Americans. Vaccination does," said CDC Director Erica Schwartz.¹

How the US lost measles elimination status

The Pan American Health Organization (PAHO) Measles and Rubella Elimination Regional Monitoring and Re-Verification Commission made the determination at the close of its November 10 to 13 meeting, after concluding that measles transmission in the US had continued uninterrupted for more than 12 months.² Canada, Spain, and the United Kingdom have also lost elimination status recently.²

As of November 12, CDC had recorded 5,412 confirmed cases, 5,394 from 47 jurisdictions and 18 among international visitors, compared with 2,289 cases in all of 2025.³ About 96% of 2026 cases were outbreak-associated, across 43 new outbreaks, and CDC lists 6 deaths, a figure it notes is subject to change.³

CDC funding and Epi-Aid response to measles outbreaks

Since August, CDC has provided approximately $100 million in additional funding to state and local health departments through most of 2027, including $50.2 million through the Strengthening Vaccine-Preventable Disease Prevention and Response cooperative agreement and $49.8 million through the Epidemiology and Laboratory Capacity cooperative agreement.¹ CDC also deploys Epi-Aid field teams at a jurisdiction's request. Texas, South Carolina, Virginia, Kansas, New Mexico, and Wisconsin used Epi-Aid support and brought their outbreaks under control, and Pennsylvania and New York have since requested teams.¹

"We cannot accept measles as an endemic disease again in this country," said Joseph Kanter, MD, MPH, of the Association of State and Territorial Health Officials, who called for a sustained re-elimination campaign.¹ Scott J. Becker, MS, of the Association of Public Health Laboratories, pointed to the role of laboratory testing and whole genome sequencing and the need for continued laboratory and workforce investment.¹

Declining MMR vaccination coverage in US kindergartners

The statement ties the resurgence to widening immunity gaps. Kindergarten MMR coverage fell from 95.2% in the 2019-2020 school year to 92.7% in 2023-2024,¹ below PAHO's coverage target of at least 95% for sustaining elimination.²

County-level data suggest the decline is broad. In a 2025 JAMA research letter, Johns Hopkins investigators found that 1,614 of 2,066 counties (78%) in 33 states reported lower MMR coverage after the COVID-19 pandemic than before it, with only California, Connecticut, Maine, and New York reporting increases in median county-level rates.⁴

The statement also acknowledges that some families decline vaccination for religious or personal reasons, that some children cannot be vaccinated for medical reasons, and that national survey research documented declining trust in physicians and hospitals from 2020 to 2024.¹ HHS Secretary Robert F. Kennedy Jr and Schwartz continue to recommend MMR vaccination as the most effective prevention, according to the statement.¹

What re-elimination of measles will require

The statement commits partners to measurable progress but does not specify a timeline or the benchmarks that will be used to track it.¹ Re-elimination also depends on factors outside domestic control: measles circulates in more than 100 countries, and CDC said it is working with other nations, particularly in the Americas, to limit cross-border spread.¹ Surveillance gaps are another consideration, because CDC's national count includes only confirmed cases that jurisdictions report, and state figures may be higher.³

Janet Hamilton, MPH, of the Council of State and Territorial Epidemiologists, said regaining elimination is achievable but requires a coordinated response at every level of public health.¹ Lori Tremmel Freeman, of the National Association of County and City Health Officials, emphasized the local nature of that work: "Achieving measles re-elimination as a nation can only happen with focused work and support, community by community."¹

References
  1. Centers for Disease Control and Prevention. Joint statement: loss of US measles elimination status. News release. November 17, 2026. Accessed November 17, 2026. https://www.cdc.gov/media/releases/2026/loss-of-usmeasles-elimination-status.html
  2. Reports say US loses measles elimination status after 26 years. Contagion Live. November 14, 2026. Accessed November 17, 2026. https://www.contagionlive.com/view/reports-say-us-loses-measles-elimination-status-after-26-years
  3. Centers for Disease Control and Prevention. Measles cases and outbreaks. Updated November 13, 2026. Accessed November 17, 2026. https://www.cdc.gov/measles/data-research/index.html
  4. Dong E, Saiyed S, Nearchou A, Okura Y, Gardner LM. Trends in county-level MMR vaccination coverage in children in the United States. JAMA. 2025;334(8):730-732. doi:10.1001/jama.2025.8952

Related to this article